Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (111-120 of 334) with videos related to

Pageof 34
Sort By:
Blood|April 9, 2004
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?Christian Demanet, Arend Mulder, Veronique Deneys, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasHelen P Cathro, Mark E Smolkin, Dan Theodorescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumorsAngelica Facoetti, Rosanna Nano, Paola Zelini, et al.
Cancers|August 29, 2019
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma CellsSilvia Peppicelli, Jessica Ruzzolini, Elena Andreucci, et al.
Journal for Immunotherapy of Cancer|November 22, 2018
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literatureFrancesco Sabbatino, Antonio Marra, Luigi Liguori, et al.
Oncotargets and Therapy|February 27, 2014
Ipilimumab in the treatment of metastatic melanoma: management of adverse eventsGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Perri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcomeMarkus Meissner, Torsten E Reichert, Martin Kunkel, et al.
International Journal of Cancer|February 23, 2007
Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinomaTakeshi Ogino, Shigetaka Moriai, Yoshiya Ishida, et al.
Immunologic Research|October 17, 2018
Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platformMepur H Ravindranath, Edward J Filippone, Grace Mahowald, et al.
Expert Opinion on Biological Therapy|December 10, 2020
B7-H3 targeted antibody-based immunotherapy of malignant diseasesTheodoros Michelakos, Filippos Kontos, Omar Barakat, et al.
Pageof 34

Showing results (111-120 of 334) with videos related to

Sort By:
Pageof 34
Blood|April 9, 2004
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?Christian Demanet, Arend Mulder, Veronique Deneys, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasHelen P Cathro, Mark E Smolkin, Dan Theodorescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumorsAngelica Facoetti, Rosanna Nano, Paola Zelini, et al.
Cancers|August 29, 2019
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma CellsSilvia Peppicelli, Jessica Ruzzolini, Elena Andreucci, et al.
Journal for Immunotherapy of Cancer|November 22, 2018
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literatureFrancesco Sabbatino, Antonio Marra, Luigi Liguori, et al.
Oncotargets and Therapy|February 27, 2014
Ipilimumab in the treatment of metastatic melanoma: management of adverse eventsGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Perri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcomeMarkus Meissner, Torsten E Reichert, Martin Kunkel, et al.
International Journal of Cancer|February 23, 2007
Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinomaTakeshi Ogino, Shigetaka Moriai, Yoshiya Ishida, et al.
Immunologic Research|October 17, 2018
Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platformMepur H Ravindranath, Edward J Filippone, Grace Mahowald, et al.
Expert Opinion on Biological Therapy|December 10, 2020
B7-H3 targeted antibody-based immunotherapy of malignant diseasesTheodoros Michelakos, Filippos Kontos, Omar Barakat, et al.
Pageof 34